Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2754 | 2157 | 51.6 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
133 | 3 | MELATONIN//SLEEP//JOURNAL OF PINEAL RESEARCH | 66554 |
1753 | 2 | OREXIN//GALANIN//HYPOCRETIN | 6481 |
2754 | 1 | OREXIN//HYPOCRETIN//OREXIN A | 2157 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | OREXIN | authKW | 7193049 | 36% | 65% | 778 |
2 | HYPOCRETIN | authKW | 3548480 | 19% | 62% | 404 |
3 | OREXIN A | authKW | 2656286 | 11% | 82% | 228 |
4 | OREXIN RECEPTORS | authKW | 992555 | 4% | 89% | 79 |
5 | SB 334867 | authKW | 868406 | 3% | 93% | 66 |
6 | OREXIN 1 RECEPTOR | authKW | 496860 | 2% | 95% | 37 |
7 | OREXIN RECEPTOR ANTAGONIST | authKW | 428172 | 2% | 92% | 33 |
8 | MOL NEUROSCI INTEGRAT PHYSIOL | address | 421815 | 2% | 65% | 46 |
9 | OREXIN B | authKW | 414118 | 1% | 91% | 32 |
10 | ALMOREXANT | authKW | 368524 | 1% | 96% | 27 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 17721 | 52% | 0% | 1132 |
2 | Endocrinology & Metabolism | 3376 | 16% | 0% | 348 |
3 | Physiology | 2138 | 12% | 0% | 251 |
4 | Behavioral Sciences | 1406 | 6% | 0% | 133 |
5 | Pharmacology & Pharmacy | 1336 | 17% | 0% | 359 |
6 | Clinical Neurology | 377 | 7% | 0% | 157 |
7 | Psychiatry | 311 | 5% | 0% | 117 |
8 | Chemistry, Medicinal | 212 | 4% | 0% | 80 |
9 | Psychology, Biological | 162 | 1% | 0% | 24 |
10 | Biochemistry & Molecular Biology | 102 | 11% | 0% | 229 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL NEUROSCI INTEGRAT PHYSIOL | 421815 | 2% | 65% | 46 |
2 | NARCOLEPSY | 150351 | 2% | 25% | 42 |
3 | DEP S CIRCADIAN DISORDERS | 43341 | 0% | 44% | 7 |
4 | YANAGISAWA ORPHAN RECEPTOR PROJECT | 42879 | 0% | 30% | 10 |
5 | EXPLORATORY ADV TECHNOL YANAGISAWA ORPHAN PRO | 42464 | 0% | 100% | 3 |
6 | ERATO YANAGISAWA ORPHAN RECEPTOR PROJECT | 39191 | 0% | 46% | 6 |
7 | STANFORD NARCOLEPSY | 35382 | 0% | 50% | 5 |
8 | DRUG DISCOVERY PRECLIN DEV | 34730 | 0% | 27% | 9 |
9 | EXPLORATORY ADV TECHNOL YANAGISAWA ORPHAN REC | 32350 | 0% | 57% | 4 |
10 | SLEEP 151A3 | 31846 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REGULATORY PEPTIDES | 11447 | 3% | 1% | 62 |
2 | VITAMINS AND HORMONES | 11391 | 1% | 6% | 14 |
3 | PEPTIDES | 6742 | 3% | 1% | 65 |
4 | SLEEP | 5107 | 2% | 1% | 40 |
5 | ACTA PHYSIOLOGICA | 4276 | 1% | 2% | 20 |
6 | NEUROSCIENCE | 4230 | 4% | 0% | 82 |
7 | EUROPEAN JOURNAL OF NEUROSCIENCE | 3526 | 2% | 0% | 53 |
8 | JOURNAL OF NEUROSCIENCE | 3420 | 4% | 0% | 92 |
9 | FRONTIERS IN NEUROSCIENCE | 2957 | 1% | 1% | 21 |
10 | FRONTIERS IN BEHAVIORAL NEUROSCIENCE | 2923 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OREXIN | 7193049 | 36% | 65% | 778 | Search OREXIN | Search OREXIN |
2 | HYPOCRETIN | 3548480 | 19% | 62% | 404 | Search HYPOCRETIN | Search HYPOCRETIN |
3 | OREXIN A | 2656286 | 11% | 82% | 228 | Search OREXIN+A | Search OREXIN+A |
4 | OREXIN RECEPTORS | 992555 | 4% | 89% | 79 | Search OREXIN+RECEPTORS | Search OREXIN+RECEPTORS |
5 | SB 334867 | 868406 | 3% | 93% | 66 | Search SB+334867 | Search SB+334867 |
6 | OREXIN 1 RECEPTOR | 496860 | 2% | 95% | 37 | Search OREXIN+1+RECEPTOR | Search OREXIN+1+RECEPTOR |
7 | OREXIN RECEPTOR ANTAGONIST | 428172 | 2% | 92% | 33 | Search OREXIN+RECEPTOR+ANTAGONIST | Search OREXIN+RECEPTOR+ANTAGONIST |
8 | OREXIN B | 414118 | 1% | 91% | 32 | Search OREXIN+B | Search OREXIN+B |
9 | ALMOREXANT | 368524 | 1% | 96% | 27 | Search ALMOREXANT | Search ALMOREXANT |
10 | OREXIN HYPOCRETIN | 355694 | 2% | 74% | 34 | Search OREXIN+HYPOCRETIN | Search OREXIN+HYPOCRETIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LI, JC , HU, Z , DE LECEA, L , (2014) THE HYPOCRETINS/OREXINS: INTEGRATORS OF MULTIPLE PHYSIOLOGICAL FUNCTIONS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 2. P. 332-350 | 263 | 88% | 43 |
2 | KUKKONEN, JP , (2013) PHYSIOLOGY OF THE OREXINERGIC/HYPOCRETINERGIC SYSTEM: A REVISIT IN 2012.AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. VOL. 304. ISSUE 1. P. C2-C32 | 310 | 77% | 41 |
3 | GOTTER, AL , WEBBER, AL , COLEMAN, PJ , RENGER, JJ , WINROW, CJ , (2012) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXVI. OREXIN RECEPTOR FUNCTION, NOMENCLATURE AND PHARMACOLOGY.PHARMACOLOGICAL REVIEWS. VOL. 64. ISSUE 3. P. 389 -420 | 243 | 83% | 51 |
4 | CHEN, QH , DE LECEA, L , HU, ZA , GAO, D , (2015) THE HYPOCRETIN/OREXIN SYSTEM: AN INCREASINGLY IMPORTANT ROLE IN NEUROPSYCHIATRY.MEDICINAL RESEARCH REVIEWS. VOL. 35. ISSUE 1. P. 152 -197 | 252 | 71% | 8 |
5 | LEONARD, CS , KUKKONEN, JP , (2014) OREXIN/HYPOCRETIN RECEPTOR SIGNALLING: A FUNCTIONAL PERSPECTIVE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 2. P. 294-313 | 161 | 86% | 18 |
6 | SAKURAI, T , (2014) THE ROLE OF OREXIN IN MOTIVATED BEHAVIOURS.NATURE REVIEWS NEUROSCIENCE. VOL. 15. ISSUE 11. P. 719 -731 | 125 | 87% | 49 |
7 | XU, TR , YANG, Y , WARD, R , GAO, LH , LIU, Y , (2013) OREXIN RECEPTORS: MULTI-FUNCTIONAL THERAPEUTIC TARGETS FOR SLEEPING DISORDERS, EATING DISORDERS, DRUG ADDICTION, CANCERS AND OTHER PHYSIOLOGICAL DISORDERS.CELLULAR SIGNALLING. VOL. 25. ISSUE 12. P. 2413-2423 | 155 | 84% | 25 |
8 | TSUJINO, N , SAKURAI, T , (2013) ROLE OF OREXIN IN MODULATING AROUSAL, FEEDING, AND MOTIVATION.FRONTIERS IN BEHAVIORAL NEUROSCIENCE. VOL. 7. ISSUE . P. - | 132 | 85% | 51 |
9 | LOPEZ, M , TENA-SEMPERE, M , DIEGUEZ, C , (2010) CROSS-TALK BETWEEN OREXINS (HYPOCRETINS) AND THE NEUROENDOCRINE AXES (HYPOTHALAMIC-PITUITARY AXES).FRONTIERS IN NEUROENDOCRINOLOGY. VOL. 31. ISSUE 2. P. 113-127 | 201 | 70% | 22 |
10 | KHOO, SYS , BROWN, RM , (2014) OREXIN/HYPOCRETIN BASED PHARMACOTHERAPIES FOR THE TREATMENT OF ADDICTION: DORA OR SORA?.CNS DRUGS. VOL. 28. ISSUE 8. P. 713 -730 | 154 | 77% | 9 |
Classes with closest relation at Level 1 |